论文信息 - Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer - 字舞流文

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

S. Koch | R. Cathomas | M. Fotin‐Mleczek | W. Hilbe | M. Sebastian | H. Bischoff | A. Zippelius | F. Griesinger | T. Seibel | K. Kallen | A. Papachristofilou | G. Pall | A. Schröder | M. Pless | M. Geissler | B. Scheel | T. Wehler | M. Früh | H. Hong | U. Klinkhardt | C. Weiss | J. Alt | Fatma Doener | Claudia Stosnach | U. Gnad-Vogt | Anke Muth | M. Hipp | F. Doener